McDonnell Boehnen Hulbert & Berghoff LLP attorney Bryan Helwig, Ph.D. is cited in an October 31, 2019 Law360 article entitled, “IP Law Group Urges High Court To Fix Patent Eligibility.” The U.S. Supreme Court should clarify when medical diagnostic tests can be patent-eligible, a Chicago-based intellectual property organization said Thursday, joining a number of voices asking the justices to take on an appeal of a Federal Circuit ruling that invalidated a patent on a diagnostic test for an autoimmune disease for claiming a natural law. In an amicus brief that Dr.Helwig helped to write, the Intellectual Property Law Association of Chicago urged the high court to grant Athena Diagnostics’ petition for certiorari in its dispute with the Mayo Clinic. View the article
